Stocks
TuHURA Biosciences, Inc.HURA
NASDAQHealthcareBiotechnology$1.90-3.06%
A clinical-stage biotechnology company developing immuno-oncology therapies aimed at overcoming tumor resistance mechanisms and improving responses to checkpoint inhibitors. Its pipeline focuses on agents designed to modify the tumor microenvironment and restore immune system activity against cancer...
Market Cap: $107.3M52W Range: $0.41 – $4.44
Congressional Interest in TuHURA Biosciences, Inc. (HURA)
2 members of Congress have disclosed 4 trades in TuHURA Biosciences, Inc. (HURA), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
2
Buys
3
Sells
0
Who in Congress Is Trading HURA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-07-13 | Laurel Lee | buy | $50K – $100K |
| 2024-11-25 | Laurel Lee | buy | $1K – $15K |